N-[[3-(3-氟-4-(哌嗪-1-基)苯基)-2-氧代恶唑烷-5-基]甲基]乙酰胺(154590-43-9)名称与标识符
名称
中文别名：
N-[[3-(3-氟-4-(哌嗪-1-基)苯基)-2-氧代恶唑烷-5-基]甲基]乙酰胺;
英文别名：
N-[[3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl]methyl]acetamide;N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide;SCHEMBL1498511;SY289759;154590-43-9;N-[[3-(3-fluoro-4-piperazin-1-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;MFCD18089805;DSRPYQXHWUDRBP-UHFFFAOYSA-N;N-[3-(3-fluoro-4-piperazin-1-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide;N-{[(5S)-3-[3-FLUORO-4-(PIPERAZIN-1-YL)PHENYL]-2-OXO-1,3-OXAZOLIDIN-5-YL]METHYL}ACETAMIDE;Acetamide,N-[[(5S)-3-[3-fluoro-4-(1-piperazinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-;EGA59066;
标识符
InChIKey：
DSRPYQXHWUDRBP-UHFFFAOYSA-N
Inchi：
1S/C16H21FN4O3/c1-11(22)19-9-13-10-21(16(23)24-13)12-2-3-15(14(17)8-12)20-6-4-18-5-7-20/h2-3,8,13,18H,4-7,9-10H2,1H3,(H,19,22)
SMILES：
FC1C=C(C=CC=1N1CCNCC1)N1C(=O)OC(CNC(C)=O)C1
![N-[[3-[4-[4-(2-氰基乙基)-1-哌嗪基]-3-氟苯基]-2-氧代-5-恶唑烷基]甲基]乙酰胺](http://hg.y866.cn/compound/lib/scimg/cas/150/154590-46-2.png "N-[[3-[4-[4-(2-氰基乙基)-1-哌嗪基]-3-氟苯基]-2-氧代-5-恶唑烷基]甲基]乙酰胺")
![4-[4-[5-[(乙酰氨基)甲基]-2-氧代-3-恶唑烷基]-2-氟苯基]-1-哌嗪甲酸叔丁酯](http://hg.y866.cn/compound/lib/scimg/cas/150/154591-03-4.png "4-[4-[5-[(乙酰氨基)甲基]-2-氧代-3-恶唑烷基]-2-氟苯基]-1-哌嗪甲酸叔丁酯")
![4-[4-[5-(氨基甲基)-2-氧代-3-恶唑烷基]-2-氟苯基]-1-哌嗪甲酸叔丁酯](http://hg.y866.cn/compound/lib/scimg/cas/150/154590-42-8.png "4-[4-[5-(氨基甲基)-2-氧代-3-恶唑烷基]-2-氟苯基]-1-哌嗪甲酸叔丁酯")
![N-[[3-(3-氟-4-(哌嗪-1-基)苯基)-2-氧代恶唑烷-5-基]甲基]乙酰胺结构式图片|154590-43-9结构式图片](http://hg.y866.cn/compound/lib/scimg/cas/150/154590-43-9.png?t=639038430982773098)
